Richard A. Paulson
President and CEO at Karyopharm Therapeutics Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Karyopharm Therapeutics Inc., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Karyopharm Therapeutics Inc. May 29, 202482.7%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 14, 2026 | Karyopharm Therapeutics Inc. | Open-market sale | −2,203 | $9.50 | $20,929 |
| May 13, 2026 | Karyopharm Therapeutics Inc. | Grant or award | +4,920 | — | — |
| Mar 2, 2026 | Karyopharm Therapeutics Inc. | Open-market sale | −12,361 | $9.41 | $116,317 |
| Feb 5, 2026 | Karyopharm Therapeutics Inc. | Grant or award | +81,060 | — | — |
| Oct 15, 2025 | Karyopharm Therapeutics Inc. | Grant or award | +114,285 | — | — |
| Sep 15, 2025 | Karyopharm Therapeutics Inc. | Open-market sale | −1,257 | $6.43 | $8,083 |
| Sep 12, 2025 | Karyopharm Therapeutics Inc. | Grant or award | +2,800 | — | — |
| May 6, 2025 | Karyopharm Therapeutics Inc. | Open-market sale | −236 | $7.12 | $1,680 |
| Apr 4, 2025 | Karyopharm Therapeutics Inc. | Open-market sale | −245 | $3.74 | $916 |
| Mar 4, 2025 | Karyopharm Therapeutics Inc. | Open-market sale | −11,694 | $6.29 | $73,555 |
| Feb 28, 2025 | Karyopharm Therapeutics Inc. | Grant or award | +20,000 | — | — |
| Feb 4, 2025 | Karyopharm Therapeutics Inc. | Open-market sale | −4,099 | $0.65 | $2,664 |
| Jan 6, 2025 | Karyopharm Therapeutics Inc. | Open-market sale | −4,055 | $0.78 | $3,163 |
| Dec 4, 2024 | Karyopharm Therapeutics Inc. | Open-market sale | −3,620 | $0.81 | $2,932 |
| Nov 5, 2024 | Karyopharm Therapeutics Inc. | Open-market sale | −3,675 | $0.91 | $3,344 |
Questions about Richard A. Paulson
What boards is Richard A. Paulson on?
Richard A. Paulson sits on the board of Karyopharm Therapeutics Inc.
What company is Richard A. Paulson the CEO of?
Richard A. Paulson is President and CEO of Karyopharm Therapeutics Inc.
How long has Richard A. Paulson served on boards?
Our records show at least 4 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.